The Geography of Prescription Pharmaceuticals Supplied to the U.S.: Levels, Trends and Implications / Neriman Beste Kaygisiz, Yashna Shivdasani, Rena M. Conti, Ernst R. Berndt.

Format:

Book

Author/Creator:

Kaygisiz, Neriman Beste.

Contributor:

National Bureau of Economic Research.

Shivdasani, Yashna.

Conti, Rena M.

Berndt, Ernst R.

Series:

Working Paper Series (National Bureau of Economic Research) no. w26524.

NBER working paper series no. w26524

Language:

English

Physical Description:

1 online resource: illustrations (black and white);

Other Title:

Geography of Prescription Pharmaceuticals Supplied to the U.S

Place of Publication:

Cambridge, Mass. National Bureau of Economic Research 2019.

Summary:

Prescription pharmaceuticals are frequently used consumer products, whose manufacturing location is commonly held as a trade secret by firms and U.S. regulatory agencies. Here we use previously non-publicly available data to describe levels and trends in the manufacturing locations of the most commonly used prescription pharmaceuticals, off-patent generic drugs, intended to be consumed by Americans. We find that the base ingredients required for the manufacturing of these prescription drugs are overwhelmingly and increasingly manufactured in non-domestic locations, specifically India and China. The manufacturing of finished prescription drugs for the American market is equally split between domestic and foreign locations, but is increasingly foreign as well. The growing American reliance on non-domestic manufacturing of prescription drugs is important for stakeholders to appreciate given current quality and pricing concerns involving these products and their potential susceptibility to interruptions in supply. We discuss implications of these levels and trends for current domestic and international policy discussions.

Notes:

Print version record

December 2019.